Premium Nahrungsergänzungsmittel | artgerecht

Phosphate Retention: Causes, Symptoms & Treatment

Phosphate retention occurs when the body accumulates excess phosphate in the blood, most commonly due to kidney disease. It can lead to serious complications such as vascular calcification.

Regular tips about health Regular tips about health

Things worth knowing about "Phosphate retention"

Phosphate retention occurs when the body accumulates excess phosphate in the blood, most commonly due to kidney disease. It can lead to serious complications such as vascular calcification.

What is Phosphate Retention?

Phosphate retention is a condition in which phosphate accumulates in the bloodstream because the kidneys are no longer able to excrete it adequately. Phosphate is an essential mineral required for bone formation, energy metabolism, and numerous cellular processes. In healthy individuals, the kidneys precisely regulate blood phosphate levels. When kidney function is impaired, blood phosphate levels rise – a condition that can progress to hyperphosphatemia (elevated blood phosphate levels) in advanced stages.

Causes

The most common cause of phosphate retention is chronic kidney disease (CKD). As kidney function declines, less phosphate can be excreted through the urine. Other causes include:

Acute kidney failure: sudden loss of the kidney's filtration capacity
Hypoparathyroidism: reduced production of parathyroid hormone (PTH), which normally promotes phosphate excretion
High phosphate intake: excessive consumption of phosphate-rich foods or phosphate additives in processed foods
Rhabdomyolysis: breakdown of muscle tissue releasing large amounts of phosphate
Tumor lysis syndrome: massive cell destruction during cancer treatment

Symptoms

In early stages, phosphate retention often causes no noticeable symptoms. As severity increases, the following symptoms may occur:

Itching (pruritus): caused by deposition of calcium-phosphate crystals in the skin
Bone pain and weakness: due to disruption of calcium and vitamin D metabolism
Muscle cramps: resulting from altered electrolyte balance
Vascular calcifications: increased risk of cardiovascular disease and stroke
Cardiovascular complications: increased risk of heart failure and arrhythmias

Diagnosis

Phosphate retention is typically diagnosed through blood tests. The following parameters are assessed:

Serum phosphate: normal range in adults approximately 0.81–1.45 mmol/l; values above this indicate hyperphosphatemia
Serum calcium: often reduced when phosphate is elevated
Parathyroid hormone (PTH): frequently elevated as a response to low calcium
Creatinine and GFR: to assess kidney function
Vitamin D (25-OH-D3): often reduced in kidney disease

Treatment

Treatment of phosphate retention depends on the underlying cause and the severity of the condition.

Dietary Measures

A low-phosphate diet is a cornerstone of treatment. Patients are advised to reduce their intake of phosphate-rich foods such as dairy products, whole grains, legumes, and processed foods containing phosphate additives (e.g., E338–E341, E450–E452).

Phosphate Binders

Phosphate binders are medications that bind phosphate in the gut and prevent its absorption. They are taken with meals and include:

Calcium-based phosphate binders: e.g., calcium carbonate, calcium acetate
Non-calcium phosphate binders: e.g., sevelamer, lanthanum carbonate
Iron-based phosphate binders: e.g., sucroferric oxyhydroxide

Dialysis

In patients with end-stage kidney disease, hemodialysis or peritoneal dialysis can help remove excess phosphate from the blood. However, the effectiveness is limited, making dietary measures and phosphate binders still necessary.

Treatment of Underlying Conditions

Optimal management of the underlying kidney disease and control of secondary hyperparathyroidism using vitamin D analogues (e.g., calcitriol, paricalcitol) or calcimimetics (e.g., cinacalcet) are also important treatment options.

References

Kidney Disease: Improving Global Outcomes (KDIGO) - CKD-MBD Update Guideline 2017: KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD). Kidney International Supplements, 7(1), 1–59.
Moe, S.M. (2008). Disorders involving calcium, phosphorus, and magnesium. Primary Care: Clinics in Office Practice, 35(2), 215–237.
National Kidney Foundation (NKF): KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. American Journal of Kidney Diseases, 42(4 Suppl 3), S1–S202, 2003.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.